##SAMPLE=<ID=NA12878_03,Gender=female,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##PIPELINE=megSAP 0.1-742-ged8ba02
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	gnomAD_sub	ESP_sub	gnomAD	phyloP	PolyPhen	Sift	OMIM	fathmm-MKL	CADD	REVEL	ClinVar	HGMD	COSMIC	NGSD_hom	NGSD_het	classification	classification_comment	validation	gene_info
chr1	45797505	45797505	C	G	het		QUAL=3753;DP=228;AF=0.50;MQM=60	MUTYH,HPDL	missense_variant,downstream_gene_variant	MUTYH:NM_001128425.1:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His,MUTYH:NM_001048174.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:NM_001293191.1:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His,MUTYH:NM_001293195.1:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His,MUTYH:NM_001048172.1:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His,MUTYH:NM_001048173.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:NM_001293196.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His,MUTYH:NM_001048171.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His,MUTYH:NM_001293190.1:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His,MUTYH:NM_001293192.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His,MUTYH:NM_012222.2:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His,HPDL:NM_032756.2:downstream_gene_variant:MODIFIER::c.*1392C>G:		rs3219489	0.3135	0.000	0.021,0.000	0.2492	0.0510	T	T,T,T,T,T,T,T,T,T,T,T,T	604933 [MUTYH (provisional) Adenomas,multiple colorectal|Gastric cancer,somatic|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas];				RCV000034684.1 [benign]; RCV000079500.5 [benign]; RCV000131427.2 [benign]; RCV000144634.1 [benign]; 	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH]; 	COSM3751252	97	568				WASH7P (inh=n/a pLI=n/a)
chr3	142188337	142188337	A	C	het	pred_pathogenic_1	QUAL=11942;DP=680;AF=0.56;MQM=60	ATR	missense_variant	ATR:NM_001184.3:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.002	0.0033	0.0033	0.0069	2.3460	T	T,D	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000145327.1 [uncertain significance]; 			0	17				ISG15 (inh=AR pLI=0.01)
chr5	131925483	131925483	G	C	het		QUAL=1006;DP=67;AF=0.49;MQM=60	RAD50	missense_variant	RAD50:NM_005732.3:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala		rs55653181	0.0002	0.0001	0.0001	0	6.3310	T	T,T,T	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder];							0	0				AGRN (inh=AR pLI=0.17)
chr7	6037057	6037057	-	A	het		QUAL=285;DP=23;AF=0.48;MQM=60	PMS2	splice_region_variant&intron_variant	PMS2:NM_000535.5:splice_region_variant&intron_variant:LOW:exon6/14:c.706-4_706-3insT:,PMS2:NR_003085.2:splice_region_variant&intron_variant:LOW:exon6/14:n.788-4_788-3insT:		rs570998668	0	0	0	0				600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];				RCV000179768.1 [benign]; 		COSM1735804	0	145				AGRN (inh=AR pLI=0.17)
chr9	17457513	17457513	A	-	hom	low_DP	QUAL=104;DP=4;AF=1.00;MQM=60	CNTLN	splice_region_variant&intron_variant	CNTLN:NM_017738.3:splice_region_variant&intron_variant:LOW:exon18/25:c.3115-9delA:	(TATATT)n	rs397766990	0.7342	0	0	0.9938											719	133				ACAP3 (inh=n/a pLI=0.04)
chr9	21971137	21971137	T	G	het	pred_pathogenic_4	QUAL=404;DP=50;AF=0.46;MQM=60	CDKN2A,C9orf53	missense_variant,synonymous_variant,3_prime_UTR_variant,downstream_gene_variant	CDKN2A:NM_001195132.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala,CDKN2A:NM_000077.4:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala,CDKN2A:NM_058195.3:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88Arg,CDKN2A:NM_058197.4:3_prime_UTR_variant:MODIFIER:exon2/3:c.*144A>C:,C9orf53:NR_024274.1:downstream_gene_variant:MODIFIER::n.*616T>G:		rs200429615	0	0.0011	0.0011	0	5.3730	D	D,D	156540 [MTAP (confirmed) Diaphyseal medullary stenosis with malignant fibrous histiocytoma]:600160 [CDKN2A (confirmed) Melanoma,cutaneous malignant,2|Melanoma and neural system tumor syndrome|Pancreatic cancer/melanoma syndrome|Orolaryngeal cancer,multiple,];						COSM4163711, COSM4163712, COSM4163709, COSM4163710	7	327	1	[1] old entry - no details available		PUSL1 (inh=n/a pLI=0.00)
chr9	98232224	98232224	A	-	het		QUAL=705;DP=57;AF=0.53;MQM=60	PTCH1,LOC100507346	splice_region_variant&intron_variant,non_coding_exon_variant	PTCH1:NM_000264.3:splice_region_variant&intron_variant:LOW:exon12/23:c.1729-11delT:,PTCH1:NM_001083607.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083606.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083604.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083605.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083602.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1531-11delT:,PTCH1:NM_001083603.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1726-11delT:,LOC100507346:NR_038982.1:non_coding_exon_variant:MODIFIER:exon4/4:n.1887delA:			0	0.0014	0.0014	0.0018				601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];							0	3				INTS11 (inh=n/a pLI=0.00)
chr11	94212930	94212930	-	A	het		QUAL=410;DP=514;AF=0.11;MQM=60	MRE11A	splice_region_variant&intron_variant	MRE11A:NM_005591.3:splice_region_variant&intron_variant:LOW:exon4/19:c.315-4_315-3insT:,MRE11A:NM_005590.3:splice_region_variant&intron_variant:LOW:exon4/18:c.315-4_315-3insT:		rs71036325	0	0	0	0				600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder];				RCV000162501.1 [likely benign]; 			0	354	1	[1] old entry - no details available		TAS1R3 (inh=n/a pLI=n/a)
chr15	43701947	43701947	A	-	het		QUAL=708;DP=58;AF=0.43;MQM=60	TP53BP1,TUBGCP4,RNU6-28P	splice_region_variant&intron_variant,downstream_gene_variant,intron_variant	TP53BP1:NM_001141980.1:splice_region_variant&intron_variant:LOW:exon24/27:c.5306-8delT:,TP53BP1:NM_001141979.1:splice_region_variant&intron_variant:LOW:exon24/27:c.5300-8delT:,TP53BP1:NM_005657.2:splice_region_variant&intron_variant:LOW:exon24/27:c.5291-8delT:,TUBGCP4:NM_001286414.1:downstream_gene_variant:MODIFIER::c.*2300delA:,TUBGCP4:NM_014444.3:downstream_gene_variant:MODIFIER::c.*2297delA:,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+18528delA:		rs397711844	0.2502	0	0	0										COSM1608394	86	522	1	[1] old entry - no details available		CCNL2 (inh=n/a pLI=0.10)
chr16	3639230	3639230	G	A	het	anno_pathogenic_hgmd	QUAL=1724;DP=109;AF=0.49;MQM=60	SLX4	missense_variant	SLX4:NM_032444.2:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0.0001	0.0002	0.3390	T	T	613278 [SLX4 (provisional) Fanconi anemia,complementation group P];					CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		0	1				TMEM88B (inh=n/a pLI=n/a)
